Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

David Linetsky
Patient Activation

Suma Ramadas, PhD
Medical Affairs

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Anil Bhaskar
Unified Customer Experience

Matt Turner
Patient Affordability

Frank X. Powers
Healthcare Challenger Brands

Frank Burrell
Scientific Storytelling

Thomas Shea
Programmatic Marketing

Paul Theisen
Patient Acquisition

Laura Blair
Medication Adherence

Matthew Durham
Omnidynamic Marketing

Mike Viscel
Increasing Engagement

Bud Bilanich
Success Coach

Brenda Snow
Authentic Patient Voice